Lysine: 455 Clinical Trials, Page 39 of 46

Hide Studies Not Open or Pending

384

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

Condition(s):Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Breast Carcinoma; Prognostic Stage IV Breast Cancer AJCC v8; Unresectable Breast Carcinoma; Metastatic Melanoma; Unresectable Melanoma; Cutaneous Squamous Cell Carcinoma; Merkel Cell Carcinoma; Soft Tissue Sarcoma; Bone Sarcoma; Sarcoma,Soft Tissue; Sarcoma of BoneLast Updated:December 6, 2023Recruiting

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.